Mitsui/BASF agree broflanilide commercialisation deal
Mitsui Chemicals Agro and BASF have agreed a long-term deal for the commercialisation of Mitsui’s insecticide, broflanilide.
Mitsui Chemicals Agro and BASF have agreed a long-term deal for the commercialisation of Mitsui’s insecticide, broflanilide. The commercialisation agreement follows the 2014 development and licensing deal between the two companies when Mitsui granted BASF exclusive worldwide rights, except in Japan and some other Asian countries where Mitsui would hold exclusive or co-exclusive rights. “We are excited to continue leveraging the expertise and capabilities of each company to offer promising innovative solutions to growers and pest management professionals seeking alternatives to existing pest-targeting chemistries,” says BASF Crop Protection’s senior vice-president of global strategic marketing, Jürgen Huff.
Broflanilide is an active ingredient with a novel mode of action, demonstrating “excellent” efficacy in the control of many problematic chewing insect pests, including caterpillars and beetles in specialty and row crops, and non-crop pests such as termites, ants, cockroaches and flies. It has potential use applications in cereals as a seed treatment for control of wireworms, as well as for foliar use in leafy and fruiting vegetables, potatoes, soybeans, cotton, maize and legumes. “We are confident that broflanilide products, with their excellent performance and novel mode of action, can contribute to those in both agriculture and professional pest management seeking effective solutions,” says the head of Mitsui Chemicals Agro’s international business division, Shoichi Kondo.
Mitsui points out that the industry’s Insecticide Resistance Action Committee (IRAC) recently approved the classification of broflanilide as a compound with a new mode of action in Group 30: GABA-gated Cl- channel allosteric modulators. Broflanilide is the only ai in IRAC Group 30. Given its different chemistry, broflanilide is a highly effective broad-use compound and a valuable new tool in resistance management, the company says.
First market introductions of broflanilide products are expected in 2020.